TREATMENT READING
Urethral Cancer
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
35 sections
- Treatment Option Overview for Urethral Cancer
- Surgery
- Radiation Therapy
- Chemotherapy
- Fluorouracil dosing
- Treatment of Distal Urethral Cancer
- Treatment Options for Female Distal Urethral Cancer
- Treatment Options for Male Distal Urethral Cancer
- Treatment of Proximal Urethral Cancer
- Treatment Options for Female Proximal Urethral Cancer
- Treatment Options for Male Proximal Urethral Cancer
- Treatment of Urethral Cancer Associated With Invasive Bladder Cancer
- Treatment of Metastatic or Recurrent Urethral Cancer
- Certain factors affect prognosis (chance of recovery) and treatment options.
- Urethral cancer is staged and treated based on the part of the urethra that is affected.
- Distal urethral cancer
- Proximal urethral cancer
- Urethral cancer can recur (come back) after it has been treated.
- Treatment Option Overview
- Key Points
- There are different types of treatment for patients with urethral cancer.
- The following types of treatment are used:
- Surgery
- Radiation therapy
- Chemotherapy
- Active surveillance
- New types of treatment are being tested in clinical trials.
- Treatment for urethral cancer may cause side effects.
- Patients may want to think about taking part in a clinical trial.
- Patients can enter clinical trials before, during, or after starting their cancer treatment.
- Follow-up tests may be needed.
- Treatment of Distal Urethral Cancer
- Treatment of Proximal Urethral Cancer
- Treatment of Urethral Cancer that Forms with Invasive Bladder Cancer
- Treatment of Metastatic or Recurrent Urethral Cancer
Health professional
Treatment Option Overview for Urethral Cancer
Information about the treatment of urethral cancer and the outcomes of therapy is derived from retrospective, single-center case series and represents a very low Level of evidence C3. Most of this information comes from the small numbers of cases accumulated over many decades at major academic centers. Therefore, the treatment in these reports is usually not standardized and spans eras of shifting supportive care practices. Because urethral cancer is rare, its treatment may also reflect extrapolation from the management of other urothelial malignancies, such as bladder cancer in the case of transitional cancers and anal cancer in the case of squamous cell carcinomas.
Sources: Level of evidence C3
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Health professional · Treatment Option Overview for Urethral Cancer
Surgery
Surgery is the mainstay of therapy for urethral cancers in both women and men.[Level of evidence C3] The surgical approach depends on tumor stage and anatomic location, and tumor grade plays a less important role in treatment decisions.[1,2] Although the traditional recommendation has been to achieve a 2-cm tumor-free margin, the optimal surgical margin has not been rigorously studied and is not well defined. The role of lymph node dissection is not clear in the absence of clinical involvement, and the role of prophylactic dissection is controversial.[2] Radiation therapy and/or chemotherapy may be added in some cases in patients with extensive disease or in an attempt at organ preservation. However, there are no clear guidelines for patient selection, and the low level of evidence precludes confident conclusions about their incremental benefit.[2,3]
Sources: Level of evidence C3 · 1 · 2 · 2 · 2 · 3
Ablative techniques, such as transurethral resection, electroresection and fulguration, or laser vaporization-coagulation, are used to preserve organ function in cases of superficial anterior tumors, although the supporting literature is scant.[2]
Sources: 2
Health professional · Treatment Option Overview for Urethral Cancer
Radiation Therapy
External-beam radiation therapy, brachytherapy, or a combination is sometimes used as the primary therapy for early-stage proximal urethral cancers, particularly in women.[Level of evidence C3] Brachytherapy may be delivered with low-dose-rate iridium Ir 192 sources using a template or urethral catheter. Definitive radiation is also sometimes used for advanced-stage tumors, but because monotherapy of large tumors has shown poor tumor control, it is more frequently incorporated into combined modality therapy after surgery or with chemotherapy.[4] There are no head-to-head comparisons of these various approaches, and patient selection may explain differences in outcomes among the regimens.[Level of evidence C3]
Sources: Level of evidence C3 · 4 · Level of evidence C3
The most commonly used tumor doses are in the range of 60 Gy to 70 Gy. Severe complication rates for definitive radiation therapy are about 16% to 20% and include fistula development, especially for large tumors invading the vagina, bladder, or rectum. Urethral strictures also occur in the setting of urethral-sparing treatment. Toxicity rates increase at doses greater than 65 Gy to 70 Gy. Intensity-modulated radiation therapy has become more common in an attempt to decrease local morbidity of the radiation.[4]
Sources: 4
Health professional · Treatment Option Overview for Urethral Cancer
Chemotherapy
The literature on chemotherapy for urethral carcinoma is anecdotal in nature and restricted to retrospective, single-center case series or case reports.[5][Level of evidence C3] A wide variety of agents used alone or in combination have been reported over the years, and their use has largely been extrapolated from experience with other urinary tract tumors.
Sources: 5 · Level of evidence C3
For squamous cell cancers, agents that have been used in penile cancer or anal carcinoma include the following:[3,5]
Sources: 3 · 5
Chemotherapy for transitional cell urethral tumors is extrapolated from experience with transitional cell bladder tumors and, therefore, usually contains the following:[1,4-7]
Sources: 1 · 4 · 7
Methotrexate, vinblastine, doxorubicin, and cisplatin.
Ifosfamide, with occasional complete responses.
Chemotherapy has been used alone for metastatic disease or in combination with radiation therapy and/or surgery for locally advanced urethral cancer. It may be used in the neoadjuvant setting with radiation therapy in an attempt to increase the resectability rate or to preserve organs.[3] However, the impact of any of these regimens on survival is not known for any stage or setting.
Sources: 3
Health professional · Treatment Option Overview for Urethral Cancer / Chemotherapy
Fluorouracil dosing
The DPYD gene encodes an enzyme that catabolizes pyrimidines and fluoropyrimidines, like capecitabine and fluorouracil. An estimated 1% to 2% of the population has germline pathogenic variants in DPYD, which lead to reduced DPD protein function and an accumulation of pyrimidines and fluoropyrimidines in the body.[8,9] Patients with the DPYD*2A variant who receive fluoropyrimidines may experience severe, life-threatening toxicities that are sometimes fatal. Many other DPYD variants have been identified, with a range of clinical effects.[8-10] Fluoropyrimidine avoidance or a dose reduction of 50% may be recommended based on the patient's DPYD genotype and number of functioning DPYD alleles.[11-13] DPYD genetic testing costs less than $200, but insurance coverage varies due to a lack of national guidelines.[14] In addition, testing may delay therapy by 2 weeks, which would not be advisable in urgent situations. This controversial issue requires further evaluation.[15]
Sources: 8 · 9 · 8 · 10 · 11 · 13 · 14 · 15
Health professional
Treatment of Distal Urethral Cancer
Health professional · Treatment of Distal Urethral Cancer
Treatment Options for Female Distal Urethral Cancer
If the malignancy is at or just within the meatus and superficial parameters (stage 0/Tis, Ta), open excision or electroresection and fulguration may be possible. Tumor destruction using neodymium:yttrium-aluminum-garnet (Nd:YAG) or CO2 laser vaporization-coagulation represents an alternative option. For large lesions (T1) and more invasive lesions (T2), brachytherapy or a combination of brachytherapy and external-beam radiation therapy (EBRT) are alternatives to surgical resection of the distal third of the urethra. Patients with T3 distal urethral lesions or lesions that recur after treatment with local excision or radiation therapy require anterior exenteration and urinary diversion.
If inguinal lymph nodes are palpable, frozen section confirmation of a tumor should be obtained. If positive for malignancy, ipsilateral lymph node dissection is indicated. If no inguinal adenopathy exists, lymph node dissection is not generally performed, and the nodes are monitored clinically.
Treatment options for female distal urethral cancer include the following:
Open excision and organ-sparing conservative surgical therapy.[1]
Sources: 1
Ablative techniques, such as transurethral resection, electroresection and fulguration, or laser vaporization-coagulation (Tis, Ta, T1 lesions).[2,3]
Sources: 2 · 3
EBRT, brachytherapy, or a combination of the two (T1, T2 lesions).[4]
Sources: 4
Anterior exenteration with or without preoperative radiation and diversion (T3 lesions or recurrent lesions).[2,3]
Sources: 2 · 3
The level of evidence for these treatment options is Level of evidence C3.
Sources: Level of evidence C3
Health professional · Treatment of Distal Urethral Cancer
Treatment Options for Male Distal Urethral Cancer
If the malignancy is in the pendulous urethra and is superficial, there is potential for long-term disease-free survival. In the rare cases that involve mucosa only (Tis, Ta), resection and fulguration may be used. For infiltrating lesions in the fossa navicularis, amputation of the glans penis may be adequate treatment. For lesions involving more proximal portions of the distal urethra, excision of the involved segment of the urethra, preserving the penile corpora, may be feasible for superficial tumors. Penile amputation is used for infiltrating lesions. Traditionally, a 2-cm margin proximal to the tumor is used, but the optimal margin has not been well studied. Local recurrences after amputation are rare.
The role of radiation therapy in the treatment of anterior urethral carcinoma in men is not well defined. Some anterior urethral cancers have been cured with radiation alone or a combination of chemotherapy and radiation therapy.[4,5]
Sources: 4 · 5
If inguinal lymph nodes are palpable, ipsilateral node dissection is indicated after frozen section confirmation of a tumor because a cure is still achievable with limited regional nodal metastases. If no inguinal adenopathy exists, lymph node dissection is not generally performed, and the nodes are monitored clinically.
Treatment options for male distal urethral cancer include the following:
Open-excision and organ-sparing conservative surgery.[1,3]
Sources: 1 · 3
Ablative techniques, such as transurethral resection, electroresection and fulguration, or laser vaporization-coagulation (Tis, Ta, T1 lesions).[2,3]
Sources: 2 · 3
Amputation of the penis (T1, T2, T3 lesions).
Radiation (T1, T2, T3 lesions, if amputation is refused).[4]
Sources: 4
Combined chemotherapy and radiation therapy.[5]
Sources: 5
The level of evidence for these treatment options is Level of evidence C3.
Sources: Level of evidence C3
Health professional
Treatment of Proximal Urethral Cancer
Health professional · Treatment of Proximal Urethral Cancer
Treatment Options for Female Proximal Urethral Cancer
Lesions of the proximal urethra or the entire length of the urethra are usually associated with invasion and a high incidence of pelvic nodal metastases. The prospects for cure are limited except in the case of small tumors. The best results have been achieved with exenterative surgery and urinary diversion, with 5-year survival rates ranging from 10% to 20%.
In an effort to shrink tumor margins, increase the resectability rate of gross tumor, and decrease local recurrence, adjunctive preoperative radiation therapy is a reasonable option. Pelvic lymphadenectomy is performed concomitantly. Ipsilateral inguinal lymph node dissection is indicated only if biopsy specimens of ipsilateral palpable adenopathy are positive on a frozen section. For tumors that do not exceed 2 cm in greatest dimension, radiation alone, nonexenterative surgery alone, or a combination of the two may be sufficient to provide an excellent outcome.
It is reasonable to consider removal of part of the pubic symphysis and the inferior pubic rami to maximize the surgical margin and reduce local recurrence. The perineal closure and vaginal reconstruction can be accomplished with the use of myocutaneous flaps.
The prognosis of female urethral cancer is related to the size of the lesion at presentation. For lesions smaller than 2 cm in diameter, a 5-year survival rate of 60% can be anticipated. For lesions larger than 4 cm in diameter, the 5-year survival rate falls to 13%.
Treatment options for female proximal urethral cancer include the following:
Preoperative radiation followed by anterior exenteration and urinary diversion with bilateral pelvic lymph node dissection, with or without inguinal lymph node dissection.[1]
Sources: 1
For tumors that do not exceed 2 cm in greatest dimension, radiation alone, nonexenterative surgery alone, or a combination of the two may be sufficient to provide an excellent outcome.[1,2]
Sources: 1 · 2
The level of evidence for these treatment options is Level of evidence C3.
Sources: Level of evidence C3
Health professional · Treatment of Proximal Urethral Cancer
Treatment Options for Male Proximal Urethral Cancer
Lesions of the bulbomembranous urethra require radical cystoprostatectomy and en bloc penectomy to achieve adequate margins of resection, minimize local recurrence, and achieve long-term, disease-free survival. Pelvic lymphadenectomy is also performed because of the high incidence of positive lymph nodes and the limited added morbidity.
Despite extensive surgery, local recurrence is common, and this event is invariably associated with eventual death from the disease. Five-year survival rates are only 15% to 20%. In an effort to shrink tumor margins, the use of preoperative adjunctive radiation therapy may be considered. In an effort to increase the surgical margins of dissection, resection of the inferior pubic rami and the lower portion of the pubic symphysis has been used. Urinary diversion is required.[3]
Sources: 3
Ipsilateral inguinal lymph node dissection is indicated if palpable ipsilateral inguinal adenopathy is found on physical examination and confirmed to be neoplasm by frozen section.
Treatment options for male proximal urethral cancer include the following:
Preoperative radiation or combined chemotherapy and radiation therapy followed by cystoprostatectomy, urinary diversion, and penectomy with bilateral pelvic lymph node dissection, with or without inguinal lymph node dissection.[4]
Sources: 4
The level of evidence for these treatment options is Level of evidence C3.
Sources: Level of evidence C3
Health professional
Treatment of Urethral Cancer Associated With Invasive Bladder Cancer
Approximately 10% (range, 4%–17%) of patients who undergo cystectomy for bladder cancer can be expected to have or to later develop clinical neoplasm of the urethra distal to the urogenital diaphragm. Factors associated with the risk of urethral recurrence after cystectomy include the following:[1,2]
Sources: 1 · 2
Tumor location at the bladder neck.
Prostatic urethral mucosal or stromal involvement.
The benefits of urethrectomy at the time of cystectomy need to be weighed against the morbidity factors, which include added operating time, hemorrhage, and the potential for perineal hernia. Tumors found incidentally on pathological examination are much more likely to be superficial or in situ in contrast to those that present with clinical symptoms at a later date, when the likelihood of invasion within the corporal bodies is high. The former lesions are often curable, and the latter are only rarely so. Indications for urethrectomy in continuity with cystoprostatectomy are the following:
Visible tumor in the urethra.
Positive swab cytology of the urethra.
Positive margins of the membranous urethra on frozen section taken at the time of cystoprostatectomy.
Multiple in situ bladder tumors that extend onto the bladder neck and proximal prostatic urethra.
If the urethra is not removed at the time of cystectomy, follow-up includes periodic cytologic evaluation of saline urethral washings.[2]
Sources: 2
Treatment options for urethral cancer associated with invasive bladder cancer include the following:
In continuity cystourethrectomy.
Monitor urethral cytology and delayed urethrectomy, if necessary.
The level of evidence for these treatment options is Level of evidence C3.
Sources: Level of evidence C3
Health professional
Treatment of Metastatic or Recurrent Urethral Cancer
Local recurrences of urethral cancer may be amenable to local modality therapy with radiation or surgery, with or without chemotherapy. For more information, see the Treatment Option Overview for Urethral Cancer section. Metastatic disease may be treated with regimens in common use for other urothelial transitional cell or squamous cell carcinomas, or anal carcinomas, depending on the histology.[1-3]
Sources: Treatment Option Overview for Urethral Cancer · 1 · 3
Treatment options for metastatic or recurrent urethral cancer include the following:
Surgical excision of locally recurrent urethral cancer after radiation therapy should be considered, if feasible.
Combination radiation therapy and wider surgical resection should be considered for locally recurrent urethral cancer after surgery alone.
Clinical trials using chemotherapy should be considered for metastatic urethral cancer. Transitional cell cancer of the urethra may respond favorably to the same chemotherapy regimens used for advanced transitional cell cancer of the bladder.[1-4]
Sources: 1 · 4
The level of evidence for these treatment options is Level of evidence C3.
Sources: Level of evidence C3
For patients · General Information About Urethral Cancer
Certain factors affect prognosis (chance of recovery) and treatment options.
The prognosis and treatment options depend on the following:
Sources: prognosis
Where the cancer formed in the urethra.
Whether the cancer has spread through the mucosa lining the urethra to nearby tissue, to lymph nodes, or to other parts of the body.
Sources: mucosa
Whether the patient is a male or female.
The patient's general health.
Whether the cancer has just been diagnosed or has recurred (come back).
Sources: recurred
For patients · Stages of Urethral Cancer
Urethral cancer is staged and treated based on the part of the urethra that is affected.
Urethral cancer is staged and treated based on the part of the urethra that is affected and how deeply the tumor has spread into tissue around the urethra. Urethral cancer can be described as distal or proximal.
Sources: Urethral cancer · distal · proximal
For patients · Stages of Urethral Cancer / Urethral cancer is staged and treated based on the part of the urethra that is affected.
Distal urethral cancer
In distal urethral cancer, the cancer usually has not spread deeply into the tissue. In women, the part of the urethra that is closest to the outside of the body (about ½ inch) is affected. In men, the part of the urethra that is in the penis is affected.
Sources: distal urethral cancer · tissue · urethra · penis
For patients · Stages of Urethral Cancer / Urethral cancer is staged and treated based on the part of the urethra that is affected.
Proximal urethral cancer
For patients · Stages of Urethral Cancer
Urethral cancer can recur (come back) after it has been treated.
The cancer may come back in the urethra or in other parts of the body.
For patients
Treatment Option Overview
For patients · Treatment Option Overview
Key Points
There are different types of treatment for patients with urethral cancer.
The following types of treatment are used:
The following types of treatment are used:
Surgery
New types of treatment are being tested in clinical trials.
Treatment for urethral cancer may cause side effects.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
For patients · Treatment Option Overview
There are different types of treatment for patients with urethral cancer.
Different types of treatments are available for patients with urethral cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Sources: urethral cancer · standard · clinical trials · research study · cancer
For patients · Treatment Option Overview
The following types of treatment are used:
For patients · Treatment Option Overview / The following types of treatment are used:
Surgery
Surgery to remove the cancer is the most common treatment for cancer of the urethra. One of the following types of surgery may be done:
Sources: Surgery · urethra
Open excision: Removal of the cancer by surgery.
Sources: Open excision
Transurethral resection (TUR): Surgery to remove the cancer using a special tool inserted into the urethra.
Sources: Transurethral resection
Electroresection with fulguration: Surgery to remove the cancer by electric current. A lighted tool with a small wire loop on the end is used to remove the cancer or to burn the tumor away with high-energy electricity.
Sources: fulguration · tumor
Laser surgery: A surgical procedure that uses a laser beam (a narrow beam of intense light) as a knife to make bloodless cuts in tissue or to remove or destroy tissue.
Sources: Laser surgery · laser beam · tissue
Partial penectomy: Surgery to remove the part of the penis surrounding the urethra where cancer has spread. Plastic surgery may be done to rebuild the penis.
Sources: penectomy · penis
Radical penectomy: Surgery to remove the entire penis. Plastic surgery may be done to rebuild the penis.
If the urethra is removed, the surgeon will make a new way for the urine to pass from the body. This is called urinary diversion. If the bladder is removed, the surgeon will make a new way for urine to be stored and passed from the body. The surgeon may use part of the small intestine to make a tube that passes urine through an opening (stoma). This is called an ostomy or urostomy. If a patient has an ostomy, a disposable bag to collect urine is worn under clothing. The surgeon may also use part of the small intestine to make a new storage pouch (continent reservoir) inside the body where the urine can collect. A tube (catheter) is then used to drain the urine through a stoma.
Sources: surgeon · urine · urinary diversion · small intestine · stoma · ostomy · urostomy · continent reservoir · catheter · drain
After the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.
Sources: chemotherapy · radiation therapy · cells · adjuvant therapy
For patients · Treatment Option Overview / The following types of treatment are used:
Radiation therapy
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:
Sources: x-rays · radiation
External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.
Sources: External radiation therapy
Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. Internal radiation therapy is also called brachytherapy.
Sources: Internal radiation therapy · radioactive · seeds
The way the radiation therapy is given depends on the type of cancer and where the cancer formed in the urethra. External and internal radiation therapy are used to treat urethral cancer.
For patients · Treatment Option Overview / The following types of treatment are used:
Chemotherapy
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type of cancer and where the cancer formed in the urethra.
Sources: drugs · injected · vein · systemic chemotherapy · cerebrospinal fluid · organ · cavity · abdomen · regional chemotherapy
For patients · Treatment Option Overview / The following types of treatment are used:
Active surveillance
Active surveillance is following a patient's condition without giving any treatment unless there are changes in test results. It is used to find early signs that the condition is getting worse. In active surveillance, patients are given certain exams and tests, including biopsies, on a regular schedule.
Sources: Active surveillance · condition · signs · biopsies
For patients · Treatment Option Overview
New types of treatment are being tested in clinical trials.
Information about clinical trials is available from the NCI website.
Sources: NCI website
For patients · Treatment Option Overview
Treatment for urethral cancer may cause side effects.
For information about side effects caused by treatment for cancer, visit our Side Effects page.
Sources: side effects · Side Effects
For patients · Treatment Option Overview
Patients may want to think about taking part in a clinical trial.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Sources: clinical trial · standard treatment
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
For patients · Treatment Option Overview
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Sources: side effects
Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s clinical trials search webpage. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Sources: clinical trials search · ClinicalTrials.gov
For patients · Treatment Option Overview
Follow-up tests may be needed.
As you go through treatment, you will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.
Sources: diagnose · stage
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back).
For patients
Treatment of Distal Urethral Cancer
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
For women, treatment may include the following:
Surgery to remove the tumor (transurethral resection), electroresection and fulguration, or laser surgery for tumors that have not spread deeply into tissue.
Sources: tissue
For men, treatment may include the following:
Surgery to remove the tumor (transurethral resection), electroresection and fulguration, or laser surgery for tumors that have not spread deeply into tissue.
Surgery to remove part of the penis (partial penectomy) for tumors that are near the tip of the penis. Sometimes nearby lymph nodes are also removed (lymph node dissection).
Sources: penis · penectomy
Surgery to remove part of the urethra for tumors that are in the distal urethra but not at the tip of the penis and have not spread deeply into tissue. Sometimes nearby lymph nodes are also removed (lymph node dissection).
Sources: distal urethra
Surgery to remove the penis (radical penectomy) for tumors that have spread deeply into tissue. Sometimes nearby lymph nodes are also removed (lymph node dissection).
Radiation therapy with or without chemotherapy.
Sources: chemotherapy
Chemotherapy given together with radiation therapy.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
For patients
Treatment of Proximal Urethral Cancer
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
For women, treatment may include the following:
For men, treatment may include the following:
Radiation therapy or radiation therapy and chemotherapy, followed by surgery (cystoprostatectomy, penectomy, lymph node dissection, and urinary diversion).
Sources: chemotherapy · cystoprostatectomy · penectomy
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
For patients
Treatment of Urethral Cancer that Forms with Invasive Bladder Cancer
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
If the urethra is not removed during surgery to remove the bladder, treatment may include the following:
Sources: urethra · bladder
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
For patients
Treatment of Metastatic or Recurrent Urethral Cancer
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of recurrent urethral cancer may include one or more of the following:
Sources: recurrent
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Studies
Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery
NCT02178241 · COMPLETED · phase2
Metastatic Ureter Carcinoma, Metastatic Urethral Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Ureter Cancer AJCC v7, Stage III Urethral Cancer...
ClinicalTrials.gov recordDisease and treatment settings
recurrent Urethral Cancer
Disease and treatment setting
Treatment of Metastatic or Recurrent Urethral Cancer
Urethral Cancer
Disease and treatment setting
Urethral Cancer